Directed gene modification via triple helix formation

Current Molecular Medicine
L Gorman, P M Glazer

Abstract

The ability to selectively target mammalian genes and disrupt or restore their function would represent an important advance in gene therapy. Mutation of a single nucleotide can often result in a non-functional gene product. Reversion of defective genes to their correct sequences could lead to permanent cures for patients with many genetic diseases. Molecules such as triplex forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs) are currently being employed to bind to double-stranded DNA. Efficient targeting of genomic DNA with these molecules will be the initial step in gene modification.

Citations

Sep 11, 2002·Neuromuscular Disorders : NMD·Thomas A Rando
Jan 28, 2003·Drug Discovery Today·David J ShueyTony Giordano
Dec 17, 2005·Nucleic Acids Research·Kristin EisenschmidtAlfred Pingoud
Oct 3, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Ilaria LamprontiRoberto Gambari
Jul 22, 2004·IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society·Raymond L Page, Sakthikumar Ambady
Oct 21, 2003·Nucleosides, Nucleotides & Nucleic Acids·Jian-Sheng Sun, Claude Hélène
Mar 11, 2003·Technology in Cancer Research & Treatment·Roberta Piva, Roberto Gambari
Dec 30, 2006·Chembiochem : a European Journal of Chemical Biology·Philipp RathertAlbert Jeltsch

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.